| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.7 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.7 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |